Azgovanc 40/1100 mg 7 capsules

Tradename

Azgovants

Azgovanc

Composition

Each capsule contains:

Omeprazole 40 mg

Sodium bicarbonate 1100 mg

Auxiliary components:

Aerosil 200, magnesium stearate and croscarmellos sodium

Properties

H + -K + -ATPase inhibitor. It inhibits the activity of H + -K + -ATP-ase in the parietal cells of the stomach and thereby blocks the final stage of the secretion of hydrochloric acid. This leads to a decrease in the level of basal and stimulated secretion, regardless of the nature of the stimulus. Due to a decrease in acid secretion, it reduces or normalizes the effect of acid on the esophagus in patients with reflux esophagitis.

Omeprazole has a bactericidal effect on

Helicobacter pylori. The eradication of H. pylori with the simultaneous use of omeprazole and antibiotics allows you to quickly stop the symptoms of the disease, achieve a high degree of healing of the damaged mucosa and persistent long-term remission, and reduce the likelihood of bleeding from the gastrointestinal tract.

Indications

Peptic ulcer and duodenal ulcer in the acute phase (including associated with Helicobacter pylori), reflux esophagitis, Zollinger-Ellison syndrome, erosive and ulcerative lesions of the stomach and duodenum associated with NSAID intake.

Method of administration and dosage:

For adults

Contraindications

Chronic liver disease (including history), childhood, hypersensitivity to omeprazole.

Precautions:

Before starting therapy, it is necessary to exclude the possibility of a malignant process (especially with a stomach ulcer), because treatment with omeprazole can mask symptoms and delay correct diagnosis.

Side effects

From the digestive system: rarely — nausea, diarrhea, constipation, abdominal pain, flatulence.

From the side of the central nervous system: rarely — headache, dizziness, weakness.

From the hematopoietic system: in some cases — anemia, eosinopenia, neutropenia, thrombocytopenia.